MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    Apraxia of eyelid opening in patients with movement disorders

    H. Conn, A. Lenka, J. Jankovic (Houston, USA)

    Objective: To determine the prevalence of apraxia of eyelid opening (AOELO) in patients with movement disorders evaluated at the Parkinson’s Disease Center and Movement Disorders…
  • 2024 International Congress

    Evaluation of unsteadiness in patients with dystonia

    K. Pillai, P. Chavan, K. Mansukhani, V. Patil, A. Sharma, H. Halani, V. Pardasani, S. Khadilkar, J. Lalkaka, R. Singh, N. Barucha (Mumbai, India)

    Objective: To evaluate the cause of unsteadiness in 4 patients with segmental dystonia Background: Mild impairment of postural control has been described in focal and…
  • 2024 International Congress

    Longitudinal Gait Speed Analysis at Prodromal and Early Stage of Parkinson’s Disease

    S. Sambin, M. Houot, F. Khoury, G. Mangone, L-L. Mariani, I. Arnulf, S. Lehericy, M. Vidailhet, J-C. Corvol (Paris, France)

    Objective: We aimed at exploring gait speed (GS) as a potential biomarker of disease evolution in early stages of PD with three objectives. 1- To…
  • 2024 International Congress

    Plasma biomarkers for rapid eye movement sleep behavior disorder in Parkinson’s disease: a prospective cohort study

    J. Lin, C. Li, R. Ou (Chengdu, China)

    Objective: We aimed to investigate the plasma biomarkers of rapid eye movement sleep behavior disorder (RBD) in a large PD cohort. Background: RBD is one of the most…
  • 2024 International Congress

    Movement Disorders Knowledge Among Medical Professionals in Central Asia

    ZH. Myrzayev, J. Sringean, R. Bhidayasiri (Almaty, Kazakhstan)

    Objective: To evaluate and recognize the knowledge of movement disorders among medical professionals in Central Asia. Background: ​​​​​​The field of movement disorders encompasses a diverse…
  • 2024 International Congress

    Effects of Sample Collection Methods on Skin Sebum Volatilome Composition in Parkinson’s Disease Patients – a Methodological Pilot Study

    V. van Midden, L. Strojnik, M. Mencin, N. Ogrinc, M. Kojović (Ljubljana, Slovenia)

    Objective: ​​​​​​To assess replicability of skin sebum volatile organic compound (VOC) composition 1) within the same subjects; 2) in frozen vs fresh samples, and 3)…
  • 2024 International Congress

    Genetic Variants and Levodopa Response in Parkinson’s Disease: Insights from MAO-B and DAT1 Polymorphisms

    S. Sarkar, A. Biswas, S. Ansari, S. Sengupta, S. Choudhury, R. Banerjee, S. Chatterjee, S. Dey, H. Kumar (Kolkata, India)

    Objective: This study aimed to find the association of genetic variations between Parkinson’s disease (PD) patients with and without levodopa-induced dyskinesia (LID). we intended to…
  • 2024 International Congress

    GBA Mutation Profile in Parkinson’s Disease: Insights from a Movement Disorders Center in Brazil

    F. Rolim, S. Lima, A. Verde, P. Matos, A. Marinho, F. Carvalho (Fortaleza, Brazil)

    Objective: To identify the prevalence of pathogenic variants of the GBA1 mutation among patients with parkinsonism who have undergone genetic testing. Background: GBA gene encodes…
  • 2024 International Congress

    Rare Variant Association Analysis in Kazakhstani Parkinson’s Disease Population: Preliminary Results from GP2 CAT-PD Study

    M. Isayan, N. Zharkinbekova, S. Abdraimova, CH. Shashkin, ZH. Myrzayev, V. Akhmetzhanov, A. Karimova, M. Ganieva, Z. Tavadyan, S. Khachatryan, M. Beridze, S. Sopromadze, I. Khatiashvilli, M. Kekenadze, K. Ceferov, V. Escott-Price, J. Hardy, H. Houlden, R. Kaiyrzhanov (Yerevan, Armenia)

    Objective: To identify rare genetic variants in genes, previously associated with Parkinson’s disease (PD) within a population consisting of individuals with PD and unaffected controls…
  • 2024 International Congress

    Screening for newly PD-associated RAB32 p.S71R variant in Latin America

    M. Rivera Paz, E. Waldo, T. Leal, P. Reyes-Pérez, M. Inca-Martinez, S. Alcauter, I. Amorín, M. Cornejo-Olivas, E. Dieguez, I. Estrada-Bellmann, A. Hernández-Medrano, M. Jimenez-Del-Rio, A. Lescano, B. Muñoz Ospina, K. Nuytemans, J. Orozco, V. Raggio, M. Rentería, J. Rios-Pinto, M. Rodriguez-Violante, K. Salinas Barboza, A. Schuh, C. Velez-Pardo, I. Mata (Cleveland, USA)

    Objective: Our aim was to identify whether a novel putative pathogenic variant in RAB32, a gene recently associated with familial forms of Parkinson’s Disease (PD),…
  • « Previous Page
  • 1
  • …
  • 526
  • 527
  • 528
  • 529
  • 530
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley